glp-1 drugs and gastroparesis Genetics: How Genes Affect Appetite, Semaglutide, Tirzepatide Response What Patients Should Know About

However, the final treatment plan must be personalized according to the specific deficits that require addressing or are likely to need rectification in future

Maybe so

Can GLP-1 drugs benefit patients who are not obese

It is also appreciated that gastroparesis has clinical implications beyond that of symptoms, including malnutrition, glycaemic instability and impaired absorption of orally administered drugs

Anna Lembke, a Stanford University addiction medicine specialist, told The Associated Press that while some clinicians are already prescribing GLP-1s off-label for addiction, the drugs dont work the same way for everyone and carry risks, including gastrointestinal side effects, pancreatitis and kidney conditions, that must be weighed